We bring you the latest news from the healthcare about the health care in the United Kingdom.

dinsdag 27 februari 2018

Oncogenesis - Table of Contents alert Volume 7, February 2018

Oncogenesis

Advertisement
npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.
 
Explore the benefits of submitting your manuscript.

TABLE OF CONTENTS

Volume 7 (February 2018)

In this issue
Article

Sign up for e-alerts Sign up for e-alerts
Web feed

Article

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma

Marta Di Martile, Marianna Desideri, Maria Grazia Tupone, Simonetta Buglioni, Barbara Antoniani et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0026-x

Abstract | Full Text

A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX

Yaqi Hu, Xu Guo, Jinxia Wang, Yankun Liu, Huijie Gao et al.

Oncogenesis 2018 7: 10.1038/s41389-017-0010-x

Abstract | Full Text

Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype

Ulrich A. Hirt, Irene C. Waizenegger, Norbert Schweifer, Christian Haslinger, Daniel Gerlach et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0032-z

Abstract | Full Text

MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer

Sonam Kumari, Sheema Khan, Subash C. Gupta, Vivek K. Kashyap, Murali M. Yallapu et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0031-0

Abstract | Full Text

FGF1 induces resistance to chemotherapy in ovarian granulosa tumor cells through regulation of p53 mitochondrial localization

Sevasti Manousakidi, Arnaud Guillaume, Caroline Pirou, Sylvina Bouleau, Bernard Mignotte et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0033-y

Abstract | Full Text

TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR

Xu Zhang, Lisha Wu, Ta Xiao, Ling Tang, Xuekun Jia et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0030-1

Abstract | Full Text

Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer

J. L. Hu, G. Y. He, X. L. Lan, Z. C. Zeng, J. Guan et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0028-8

Abstract | Full Text

Targeting estrogen receptor beta (ERߩ for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERߠexpression and functionality

Giulia Pinton, Stefan Nilsson & Laura Moro

Oncogenesis 2018 7: 10.1038/s41389-018-0027-9

Abstract | Full Text

Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1

Siri Amanda Tvingsholm, Malene Bredahl Hansen, Knut Kristoffer Bundgaard Clemmensen, Ditte Marie Brix, Bo Rafn et al.

Oncogenesis 2018 7: 10.1038/s41389-017-0014-6

Abstract | Full Text

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma

Feng Mao, Camilla Holmlund, Mahmood Faraz, Wanzhong Wang, Tommy Bergenheim et al.

Oncogenesis 2018 7: 10.1038/s41389-017-0012-8

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature